CENTEX CORP
8-K, 1995-06-09
OPERATIVE BUILDERS
Previous: CASH MANAGEMENT TRUST OF AMERICA, N-30D, 1995-06-09
Next: CENTRAL & SOUTH WEST CORP, 8-K, 1995-06-09



<PAGE>   1

                       SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C.  20549

                                    FORM 8-K

                                 CURRENT REPORT


                     Pursuant to Section 13 or 15(d) of The
                        Securities Exchange Act of 1934

                         Date of Report:  June 5, 1995
                       (Date of earliest event reported)


                               CENTEX CORPORATION
             (Exact name of Registrant as specified in its charter)

<TABLE>
<S>                                          <C>                                     <C>
        Nevada                                      1-6776                                       75-0778259
(State of Incorporation)                     (Commission File No.)                   (I.R.S. Employer Identification No.)

            3333 Lee Parkway
               Suite 1200
             Dallas, Texas                                                                          75219
(Address of principal executive offices)                                                          (Zip Code)
</TABLE>


       Registrant's Telephone Number, Including Area Code: (214) 559-6500
<PAGE>   2
Item 5.  Other Events.

         Reference is hereby made to the Registrant's Registration Statement on
Form S-3 (File No. 33-59030), filed with the Securities and Exchange Commission
( the "Commission") on March 3, 1993, and declared effective thereby on March
23, 1993 (the "Registration Statement"), pursuant to which the Registrant
registered $100,000,000 aggregate principal amount of its Subordinated Debt
Securities, various series (the "Securities"), for offering and sale in
accordance with applicable provisions of the Securities Act of 1933, as
amended.

         On June 5, 1995, the Registrant entered into an Underwriting Agreement
dated such date (the "Underwriting Agreement"), with NationsBanc Capital
Markets, Inc. (the "Underwriter"), relating to the proposed purchase by the
Underwriter of the Securities covered by the Registration Statement.  A copy of
the Underwriting Agreement in the form in which it was executed is filed
herewith as Exhibit 1(a).

         Pursuant to the Underwriting Agreement, on June 5, 1995, the
Registrant entered into a Pricing Agreement dated such date (the "Pricing
Agreement"), with the Underwriter, relating to $100,000,000 aggregate principal
amount of the Registrant's 7-3/8% Subordinated Debentures due June 1, 2005 (the
"Debentures"), covered by the Registration Statement.  The Pricing Agreement
provides for the purchase by the Underwriter on June 9, 1995 of the Debentures
in accordance with the terms set forth therein.  A copy of the Pricing
Agreement in the form in which it was executed is filed herewith as Exhibit
1(b).

         The Registrant entered into an Indenture dated as of March 12, 1987,
with Texas Commerce Bank National Association, as trustee ("Trustee"), with
respect to the Securities.  A copy of the Indenture in the form in which it was
executed is incorporated herein by reference as Exhibit 4(a).

         Pursuant to the Indenture, the Registrant and the Trustee entered into
an Indenture Supplement dated as of June 9, 1995, providing for the issuance of
the Debentures (the "Indenture Supplement").  A copy of the Indenture
Supplement in the form in which it was executed is filed herewith as Exhibit
4(b).

Item 7.  Financial Statements and Exhibits.

         (c)     Exhibits

<TABLE>
<CAPTION>
         Exhibit No.      Description
         -----------      -----------
             <S>          <C>
             1(a)         Underwriting Agreement dated June 5, 1995, between the Registrant and the Underwriter

             1(b)         Pricing Agreement dated June 5, 1995, between the Registrant and the Underwriter
</TABLE>





                                    - 2 -
<PAGE>   3
<TABLE>
             <S>          <C>
             4(a)         Indenture dated as of March 12, 1987, between the Registrant and the Trustee (incorporated by
                          reference to Exhibit 4.7 to the Joint Annual Report on Form 10-K of the Registrant, 3333
                          Holding Corporation and Centex Development Company, L.P. for the fiscal year ended March 31,
                          1993)

             4(b)         Indenture Supplement dated as of June 9, 1995, with respect to the Debentures, between the
                          Registrant and the Trustee
</TABLE>

                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned thereunto duly authorized.


                               CENTEX CORPORATION



<TABLE>
<S>                            <C>   <C>
June 9, 1995                   By:   /S/ MICHAEL S. ALBRIGHT               
                                     --------------------------------------
                                     Michael S. Albright, Vice President
                                     - Finance and Controller
</TABLE>





                                     - 3 -
<PAGE>   4
                               INDEX TO EXHIBITS


<TABLE>
<CAPTION>
Exhibit No.      Description                                                                              Sequential Page
- -----------      -----------                                                                              ---------------
   <S>           <C>
   1(a)          Underwriting Agreement dated
                 June 5, 1995, between the
                 Registrant and the Underwriter

   1(b)          Pricing Agreement dated
                 June 9, 1995, between the
                 Registrant and the Underwriter

   4(a)          Indenture dated as of March 12, 1987,
                 between the Registrant
                 and the Trustee (incorporated by reference to
                 Exhibit 4.7 to the Joint Annual
                 Report on Form 10-K of the Registrant,
                 3333 Holding Corporation and
                 Centex Development Company, L.P.
                 for the fiscal year ended March 31, 1993)

   4(b)          Indenture Supplement dated as
                 of June 9, 1995, with respect
                 to the Debentures, between the
                 Registrant and the Trustee



</TABLE>


                                     - 4 -

<PAGE>   1
                                                                   EXHIBIT 1(a)

                               CENTEX CORPORATION

                          Subordinated Debt Securities


                             UNDERWRITING AGREEMENT


                                                                    June 5, 1995

To the Representatives of the
 several Underwriters named
 in the respective Pricing
 Agreements hereinafter
 described.

Dear Sirs:

         From time to time Centex Corporation, a Nevada corporation (the
"Company"), proposes to enter into one or more Pricing Agreements (each a
"Pricing Agreement") in the form of Annex I hereto, with such additions and
deletions as the parties thereto may determine, and, subject to the terms and
conditions stated herein and therein, to issue and sell to the firms named in
Schedule I to the applicable Pricing Agreement (such firms constituting the
"Underwriters" with respect to such Pricing Agreement and the securities
specified therein) certain of its subordinated debt securities (the
"Securities") specified in Schedule II to such Pricing Agreement (with respect
to such Pricing Agreement, the "Designated Securities").

         The term and rights of any particular issuance of Designated
Securities shall be as specified in the Pricing Agreement relating thereto and
in or pursuant to the indenture (the "Indenture") identified in such Pricing
Agreement.

         1.      Particular sales of Designated Securities may be made from
time to time to the Underwriters of such Securities, for whom you, designated
as representatives of the Underwriters of such Securities in the Pricing
Agreement relating thereto, will act as representatives (the
"Representatives").  The term "Representative" also refers to a single firm
acting as sole representative of the Underwriters and to Underwriters who act
without any firm being designated as their representative.  This Underwriting
Agreement (this "Agreement") shall not be construed as an obligation of the
Company to sell any of the Securities or as an obligation of any of the
Underwriters to purchase any of the Securities.  The obligation of the Company
to issue and sell any of the Securities and the obligation of any of the
Underwriters to purchase any of the Securities shall be evidenced by the
Pricing Agreement with respect to the Designated Securities specified therein.
Each Pricing Agreement shall specify the aggregate principal amount of such
Designated Securities, the initial public offering price of such Designated
Securities, the purchase price to the Underwriters of such Designated
Securities, the names of the Underwriters of such Designated Securities, the
names of the Representatives of such Underwriters and the principal amount of
such Designated Securities to be purchased by each Underwriter and shall set
forth the date, time and manner of delivery of such Designated Securities and
payment therefor.  The Pricing Agreement shall also specify (to the extent not
set forth in the Indenture and the registration statement and prospectus with
respect thereto) the terms of such Designated Securities.  A Pricing Agreement
shall be in the form of an executed writing (which may be in counterparts), and
<PAGE>   2
may be evidenced by an exchange of telegraphic communications or any other
rapid transmission device designed to produce a written record of
communications transmitted.  The obligations of the Underwriters under this
Agreement and each Pricing Agreement shall be several and not joint.

         2.      The Company represents and warrants to, and agrees with, each
of the Underwriters that:

                 (a)      A registration statement (File No. 33-59030) in
         respect of the Securities has been filed with the Securities and
         Exchange Commission (the "Commission") in the form heretofore
         delivered or to be delivered to the Representatives and, excluding
         exhibits to such registration statement, to the Representatives for
         each of the other Underwriters, and such registration statement in
         such form has been declared effective by the Commission and no stop
         order suspending the effectiveness of such registration statement has
         been issued and no proceeding for that purpose has been initiated or
         threatened by the Commission (any preliminary prospectus included in
         such registration statement being hereinafter called a "Preliminary
         Prospectus;" the various parts of such registration statement,
         including all exhibits thereto (other than the Statement of
         Eligibility Under the Trust Indenture Act of 1939 of a Corporation
         Designated to Act as Trustee on Form T-1), each as amended, at the
         time such part became effective, being hereinafter collectively called
         the "Registration Statement;" the prospectus relating to the
         Securities and the prospectus supplement relating to any particular
         issuance of Designated Securities, in the form in which it has most
         recently been filed, or transmitted for filing, with the Commission on
         or prior to the date of this Agreement, being hereinafter collectively
         called the "Prospectus;" any reference herein to any Preliminary
         Prospectus or the Prospectus shall be deemed to refer to and include
         the documents incorporated by reference therein pursuant to Item 12 of
         Form S-3 under the Securities Act of 1933, as amended (the "Act"), as
         of the date of such Preliminary Prospectus or Prospectus, as the case
         may be; any reference to any amendment or supplement to any
         Preliminary Prospectus or Prospectus shall be deemed to refer to and
         include any documents filed after such date under the Securities
         Exchange Act of 1934, as amended (the "Exchange Act"), and
         incorporated by reference in such amendment or supplement; and any
         reference to the Prospectus, as amended or supplemented, shall be
         deemed to refer to the Prospectus as amended or supplemented in
         relation to the applicable Designated Securities in the form in which
         it is first filed, or transmitted for filing, with the Commission
         pursuant to Rule 424 under the Act, including any documents
         incorporated by reference therein as of the date of such filing or
         transmission);

                 (b)      The documents incorporated by reference in the
         Prospectus, when they were filed with the Commission, conformed in all
         material respects to the requirements of the Exchange Act and the
         rules and regulations of the Commission thereunder; and any further
         documents so filed and incorporated by reference in the Prospectus,
         when such documents are filed with the Commission, will conform in all
         material respects to the requirements of the Exchange Act and the
         rules and regulations of the Commission thereunder;

                 (c)      Each part of the Registration Statement and the
         Prospectus conforms, and any amendments or supplements to the
         Registration Statement or the Prospectus will conform, on the date of
         filing thereof with the Commission,




                                     -2-
<PAGE>   3
         in all material respects to the requirements of the Act and the Trust
         Indenture Act of 1939, as amended (the "Trust Indenture Act"), as
         applicable, and the rules and regulations of the Commission
         thereunder; the Registration Statement and any amendment thereto, as
         of the applicable effective date, did not or will not contain an
         untrue statement of a material fact or omit to state a material fact
         required to be stated therein or necessary to make the statements
         therein not misleading; the Prospectus and any supplement thereto, as
         of the applicable filing date, did not or will not include an untrue
         statement of a material fact or omit to state a material fact
         necessary to make the statements therein, in light of the
         circumstances under which they were made, not misleading; provided,
         however, that this representation and warranty shall not apply to any
         statements or omissions made in reliance upon and in conformity with
         information furnished in writing to the Company by or on behalf of an
         Underwriter of Designated Securities expressly for use in the
         Prospectus, as amended or supplemented, relating to such Securities;

                 (d)      Neither the Company nor any of its subsidiaries has
         sustained since the date of the latest audited financial statements
         included or incorporated by reference in the Prospectus any material
         loss or interference with its business from fire, explosion, flood or
         other calamity, whether or not covered by insurance, or from any labor
         dispute or court or governmental action, order or decree, resulting in
         an adverse effect on the business, assets, financial position or
         prospects of the Company and its subsidiaries taken as a whole,
         otherwise than as set forth or contemplated in the Prospectus; and,
         since the respective dates as of which information is given in the
         Registration Statement and the Prospectus, except as otherwise set
         forth or contemplated in the Prospectus: (i) there has not been any
         material change in the capital stock or long-term debt of the Company
         or any of its subsidiaries; (ii) there has not been any material
         adverse change, or any development involving a prospective material
         adverse change, in or affecting the business, assets, financial
         position or prospects of the Company and its subsidiaries, taken as a
         whole, otherwise than as set forth or contemplated in the Prospectus;
         (iii) no event has occurred that would result in a material write-down
         in assets; (iv) there have been no material transactions entered into
         by the Company, other than those publicly disclosed or in the ordinary
         course of business; (v) the Company has not repurchased any of its
         outstanding capital stock except as set forth in or contemplated by
         the Prospectus; and (vi) there have been no dividends or distributions
         of any kind declared, paid or made by the Company in respect of its
         capital stock except for regular cash dividends paid in the ordinary
         course of business;

                 (e)      The Company and its subsidiaries have indefeasible
         title in fee simple to all real property and indefeasible title to all
         personal property owned by them, in each case free and clear of all
         liens, encumbrances and defects except such as are described in the
         Prospectus or such as are not material to the business of the Company
         and its subsidiaries, taken as a whole; and any real property and
         buildings held under lease by the Company and its subsidiaries are
         held by them under leases that are valid, subsisting and in full force
         and effect, with such exceptions as are not material to the business
         of the Company and its subsidiaries, taken as a whole;

                 (f)      The Company has been duly incorporated and is validly
         existing as a corporation in good standing under the laws of the State
         of Nevada, and





                                      -3-
<PAGE>   4
         each subsidiary of the Company has been duly incorporated and is
         validly existing as a corporation in good standing under the laws of
         its jurisdiction of incorporation; each of the Company and its
         subsidiaries has full power and authority (corporate and other) to own
         its properties and conduct its business as described, or incorporated
         by reference, in the Prospectus, and has been duly qualified as a
         foreign corporation for the transaction of business and is in good
         standing under the laws of each other jurisdiction in which it owns or
         leases properties, or conducts any business, so as to require such
         qualification, or is subject to no material liability or disability by
         reason of the failure to be so qualified in any such jurisdiction;

                 (g)      The Company has an authorized capitalization as set
         forth, or as incorporated by reference, in the Prospectus, and all of
         the outstanding shares of capital stock of the Company have been duly
         and validly authorized and issued and are fully paid and
         nonassessable; and all of the outstanding shares of capital stock of
         each subsidiary of the Company have been duly and validly authorized
         and issued, are fully paid and nonassessable and (except for
         directors' qualifying shares and except as otherwise set forth in the
         Prospectus) are owned directly or indirectly by the Company, free and
         clear of all liens, encumbrances, equities or claims affecting
         transferability or voting except as set forth in the Prospectus;

                 (h)      The Securities have been duly authorized, and, when
         Designated Securities are executed, authenticated, issued and
         delivered against payment therefor pursuant to this Agreement, the
         Indenture and the Pricing Agreement with respect to such Designated
         Securities, such Designated Securities will have been duly executed,
         authenticated, issued and delivered and will constitute valid and
         legally binding obligations of the Company, enforceable against the
         Company in accordance with their terms, subject, as to enforcement, to
         bankruptcy, insolvency, reorganization and other laws of general
         applicability relating to or affecting creditors' rights and to
         general equity principles, and entitled to the benefits provided by
         the Indenture, which has been or will be incorporated by reference as
         an exhibit to the Registration Statement; the Indenture has been duly
         authorized, executed and delivered by the Company and constitutes a
         valid and legally binding instrument, enforceable against the Company
         in accordance with its terms, subject, as to enforcement, to
         bankruptcy, insolvency, reorganization and other laws of general
         applicability relating to or affecting creditors' rights and to
         general equity principles; at the Time of Delivery (as defined in
         Section 4 hereof), the Indenture will have been duly qualified under
         the Trust Indenture Act; and the Securities and Indenture will conform
         in all material respects to the descriptions thereof in the
         Prospectus;

                 (i)      The issue and sale of the Securities and the
         compliance by the Company with all of the provisions of the
         Securities, the Indenture, this Agreement and any Pricing Agreement,
         and the consummation of the transactions herein and therein
         contemplated will not conflict with or result in a breach of any of
         the terms or provisions of, or constitute a default under, any
         indenture, mortgage, deed of trust, loan agreement or other agreement
         or instrument to which the Company or any of its subsidiaries is a
         party or by which the Company or any of its subsidiaries is bound or
         to which any of the property or assets of the Company or any of its
         subsidiaries is subject, nor will such action result in any violation
         of the provisions of the Articles of Incorporation, as amended or
         restated,





                                      -4-
<PAGE>   5
         or the Bylaws of the Company or any statute or order, rule or
         regulation of any court or governmental agency or body having
         jurisdiction over the Company or any of its subsidiaries or any of
         their properties; and no consent, approval, authorization, order,
         registration or qualification of or with any such court or
         governmental agency or body is required for the issuance and sale of
         the Securities or the consummation by the Company of the other
         transactions contemplated by this Agreement or any Pricing Agreement
         or the Indenture, except such as have been, or will have been prior to
         the Time of Delivery, obtained under the Act and the Trust Indenture
         Act and such consents, approvals, authorizations, registrations or
         qualifications as may be required under state securities or Blue Sky
         laws in connection with the purchase and distribution of the
         Securities by the Underwriters;

                 (j)      Other than as set forth or contemplated in the
         Prospectus, there are no legal or governmental proceedings pending to
         which the Company or any of its subsidiaries is a party or of which
         any property of the Company or any of its subsidiaries is the subject
         that, if determined adversely to the Company or any of its
         subsidiaries, would individually or in the aggregate have a material
         adverse effect on the consolidated financial position, stockholders'
         equity or results of operations of the Company and its subsidiaries;
         and, to the best of the Company's knowledge, no such proceedings are
         threatened or contemplated by governmental authorities or threatened
         by others;

                 (k)      Arthur Andersen LLP, who have certified certain
         financial statements of the Company and its subsidiaries, are
         independent public accountants as required by the Act and the rules
         and regulations of the Commission thereunder;

                 (l)      The Company has no knowledge of any default in any
         material obligation to be performed by any party to any agreement to
         which it or any of its subsidiaries is a party, which default or
         defaults in the aggregate would have a material adverse effect upon
         the business, assets, financial position, or prospects of the Company
         and its subsidiaries, considered as a whole;

                 (m)      The consolidated financial statements of the Company
         and its subsidiaries, including accompanying notes, included or
         incorporated by reference in the Prospectus, comply in all material
         respects with the requirements of the Act and fairly present the
         consolidated financial position and the consolidated results of the
         operations of the Company and its subsidiaries at the respective dates
         and for the respective periods to which they apply, and such financial
         statements have been prepared in conformity with generally accepted
         accounting principles, consistently applied throughout the periods
         involved except as may be expressly stated in the notes thereto.  The
         financial information and statistical data set forth in the Prospectus
         under the caption "Summary of Selected Financial Data" are fairly
         presented and prepared on a basis consistent with such consolidated
         financial statements or the books and records of the Company, as the
         case may be, unless otherwise stated in the Prospectus;

                 (n)      Except as described in the Prospectus, the Company
         and each of its subsidiaries have all necessary licenses,
         certificates, permits, authorizations, approvals, rights and orders of
         and from all governmental





                                      -5-
<PAGE>   6
         agencies or bodies having jurisdiction over the Company or any of its
         subsidiaries to own their respective properties and conduct their
         respective businesses as described in the Prospectus, the failure to
         possess or the failure to operate in compliance with which would have
         a material adverse effect on the business of the Company and its
         subsidiaries, taken as a whole, and the Company has received no notice
         of proceedings relating to the revocation or modification of any such
         certificate, authority or permit that, singly or in the aggregate, if
         the subject of an unfavorable decision, ruling or finding, would
         materially adversely affect the business, assets, financial position
         or prospects of the Company and its subsidiaries, taken as a whole;

                 (o)      This Agreement has been duly and validly authorized,
         executed and delivered by the Company and is a valid and binding
         agreement of the Company, and the Pricing Agreement with respect to
         the Designated Securities, when executed and delivered by the Company,
         will constitute a valid and binding agreement of the Company,
         enforceable against the Company in accordance with its terms, subject,
         in each case, as to enforcement, to bankruptcy, insolvency,
         reorganization, and other laws of general applicability relating to or
         affecting creditors' rights, and to general equity principles, and
         except to the extent that rights of indemnification hereunder may be
         limited by applicable laws or equity principles;

                 (p)      Except as described in the Prospectus, each of the
         Company and its subsidiaries owns or possesses all of the patents,
         trademarks, service marks, trade names, copyrights and licenses and
         rights with respect to the foregoing, necessary for the present
         conduct of its business, without any known conflict with the rights of
         others, the result of which conflict would materially and adversely
         affect the business, assets, financial position or prospects of the
         Company and its subsidiaries, taken as a whole;

                 (q)      There are no contracts, indentures, mortgages, loan
         agreements, notes, bonds, debentures, other evidences of indebtedness,
         leases or other agreements or instruments of the Company of a
         character required to be described or referred to in the Registration
         Statement or the Prospectus or to be filed as exhibits to the
         Registration Statement that are not described or referred to or filed
         as required;

                 (r)      No labor disturbance exists with the employees of the
         Company or any of its subsidiaries, or, to the best of the Company's
         knowledge, is imminent, that would result in a material adverse effect
         upon the Company and its subsidiaries, taken as a whole, and the
         Company has not received notice of any existing or imminent labor
         disturbance by the employees of any of its principal suppliers, that
         might reasonably be expected to materially adversely affect the
         business, assets, financial position or prospects of the Company and
         its subsidiaries, taken as a whole; and

                 (s)      The conditions to the use of a registration statement
         on Form S-3 under the Act, as set forth in the General Instructions to
         Form S-3, have been satisfied with respect to the Company and the
         Registration Statement and Prospectus.

         3.      Upon the execution of the Pricing Agreement applicable to any
Designated Securities and authorization by the Representatives of the release
of such Designated Securities, the several Underwriters propose to offer such
Designated





                                      -6-
<PAGE>   7
Securities for sale upon the terms and conditions set forth in the Prospectus,
as amended or supplemented.

         4.      Designated Securities to be purchased by each Underwriter
pursuant to the Pricing Agreement relating thereto, in definitive or book-entry
form, as specified in the Pricing Agreement, and in such authorized
denominations and registered in such names as the Representatives may request
upon at least forty-eight hours' prior notice to the Company, shall be
delivered by or on behalf of the Company to the Representatives for the account
of such Underwriter, against payment by such Underwriter or on its behalf of
the purchase price therefor (by wire transfer of immediately available funds to
such bank account or accounts as may be specified by the Company) to the
Company at the time and date of delivery of such Securities or at such other
time and date as the Representatives and the Company may agree upon in writing,
such time and date being called the "Time of Delivery" for such Securities.

         5.      The Company agrees with each of the Underwriters of any 
Designated Securities:

                (a)       To make no further amendment or any supplement to the
         Registration Statement or Prospectus, as amended or supplemented,
         after the date of the Pricing Agreement relating to such Securities
         and prior to the Time of Delivery of such Securities that shall be
         disapproved by the Representatives for such Securities promptly after
         reasonable notice thereof; to advise the Representatives promptly of
         any such amendment or supplement after such Time of Delivery and
         furnish the Representatives with copies thereof; to advise the
         Representatives, promptly after it receives notice thereof, of the
         time when any amendment to the Registration Statement has been filed
         or become effective or any supplement to the Prospectus or any amended
         Prospectus has been filed, or transmitted for filing, and to furnish
         you with copies thereof; to file promptly all reports and any
         definitive proxy or information statements required to be filed by the
         Company with the Commission pursuant to Sections 13(a), 13(c), 14 or
         15(d) of the Exchange Act for so long as the delivery of a prospectus
         is required in connection with the offering or sale of such
         Securities; and during such same period to advise you, promptly after
         it receives notice thereof, of the issuance by the Commission of any
         stop order or of any order preventing or suspending the use of any
         Preliminary Prospectus or Prospectus, of the suspension of the
         qualification of such Securities for offering or sale in any
         jurisdiction, of the initiation or threatening of any proceeding for
         any such purpose, or of any request by the Commission for the amending
         or supplementing of the Registration Statement or Prospectus or for
         additional information; and, in the event of the issuance of any stop
         order or of any order preventing or suspending the use of any
         Preliminary Prospectus or Prospectus or suspending any such
         qualification, to use promptly its best efforts to obtain its
         withdrawal;

                 (b)      Promptly from time to time to take such action as the
         Representatives may reasonably request to qualify such Securities for
         offering and sale under the securities laws of such jurisdictions as
         the Representatives may request and to comply with such laws so as to
         permit the continuance of sales and dealings therein in such
         jurisdictions for as long as may be necessary to complete the
         distribution of such Securities; provided that, in connection
         therewith, the Company shall not be required





                                      -7-
<PAGE>   8
         to qualify as a foreign corporation or to file a general consent to
         service of process in any jurisdiction;

                 (c)      To furnish the Underwriters with copies of the
         Prospectus, as amended or supplemented, in such quantities as the
         Representatives may from time to time reasonably request, and, if the
         delivery of a prospectus is required at any time in connection with
         the offering or sale of the Securities and if at such time any event
         shall have occurred as a result of which the Prospectus, as then
         amended or supplemented, would include an untrue statement of a
         material fact or omit to state any material fact necessary in order to
         make the statements therein, in the light of the circumstances under
         which they were made when such Prospectus is delivered, not
         misleading, or, if, for any other reason, it shall be necessary during
         such same period to amend or supplement the Prospectus or to file
         under the Exchange Act any document incorporated by reference in the
         Prospectus in order to comply with the Act, the Exchange Act or the
         Trust Indenture Act, to notify the Representatives and, upon their
         request, to file such document and to prepare and furnish without
         charge to each Underwriter and to any dealer in securities as many
         copies as the Representatives may from time to time reasonably request
         of an amended Prospectus or a supplement to the Prospectus that will
         correct such statement or omission or effect such compliance;

                 (d)      To make generally available to its security holders
         as soon as practicable, but in any event not later than eighteen
         months after the effective date of the Registration Statement and of
         the post-effective amendment thereto, hereinafter referred to, an
         earning statement of the Company and its subsidiaries (which need not
         be audited) complying with Section 11(a) of the Act and the rules and
         regulations of the Commission thereunder (including, at the option of
         the Company, Rule 158);

                 (e)      During the period beginning from the date of the
         Pricing Agreement for such Designated Securities and continuing to and
         including the earlier of (i) the termination of trading restrictions
         for such Designated Securities, as notified to the Company by the
         Representatives, and (ii) the Time of Delivery for such Designated
         Securities, not to offer, sell, contract to sell or otherwise dispose
         of any debt securities of the Company that mature more than one year
         after such Time of Delivery and that are substantially similar to such
         Designated Securities, without the prior written consent of the
         Representatives;

                 (f)      To furnish to the holders of the Securities as soon
         as practicable after the end of each fiscal year an annual report
         (including a balance sheet and statements of income, stockholders'
         equity and cash flows of the Company and its consolidated subsidiaries
         certified by independent public accountants) and, as soon as
         practicable after the end of each of the first three quarters of each
         fiscal year (beginning with the fiscal quarter ending after the
         effective date of the Registration Statement) condensed consolidated
         financial information of the Company and its subsidiaries for such
         quarter in reasonable detail;

                 (g)      During a period of two years from the effective date
         of the Registration Statement, to furnish to the Representatives
         copies of all reports or other communications (financial or other)
         furnished to stockholders, and deliver to the Representatives (i) as
         soon as they are





                                      -8-
<PAGE>   9
         available, copies of any reports and financial statements furnished to
         or filed with the Commission or any national securities exchange on
         which the Securities or any class of securities of the Company is
         listed other than registration statements filed under the Act; and
         (ii) such additional information concerning the business and financial
         condition of the Company as the Representatives may from time to time
         reasonably request (such financial statements to be on a consolidated
         basis to the extent the accounts of the Company and its subsidiaries
         are consolidated in reports furnished to its stockholders generally or
         to the Commission), provided such information is prepared in the
         ordinary course of business and is not otherwise confidential; and
         further provided that the foregoing restriction on access to
         information shall not prohibit the Representatives' access to such
         information necessary for the defense of any litigation threatened or
         filed against the Underwriters relating to this Agreement and the
         transactions contemplated hereby; and

                 (h)      To apply in the manner described under "Use of
         Proceeds" in the Prospectus, the proceeds it receives from the sale of
         the Securities.

         6.      The Company covenants and agrees with the several Underwriters
that the Company will pay or cause to be paid the following:  (i) the fees,
disbursements and expenses of the Company's counsel and accountants in
connection with the registration of the Securities under the Act and all other
expenses in connection with the preparation, printing and filing of the
Registration Statement, any Preliminary Prospectus and the Prospectus and
amendments and supplements thereto and the mailing and delivering of copies
thereof to the Underwriters and dealers; (ii) the cost of printing or producing
any Agreement among Underwriters, this Agreement, the Pricing Agreement, the
Indenture, the Blue Sky and Legal Investment Memoranda and any other documents
in connection with the offering, purchase, sale and delivery of the Securities;
(iii) all expenses in connection with the qualification of the Securities for
offering and sale under state securities laws as provided in Section 5(b)
hereof, including the reasonable fees and disbursements of counsel in
connection with such qualification and in connection with any Blue Sky or legal
investment surveys; (iv) any fees charged by securities rating services for
rating the Securities; (v) the filing fees incident to any required review, if
any, by the National Association of Securities Dealers, Inc. of the terms of
the sale of the Securities; (vi) the cost of preparing the Securities; (vii)
the fees and expenses of the trustee designated in the Indenture (the
"Trustee") and any agent of the Trustee and the fees and disbursements of
counsel for the Trustee in connection with the Indenture and the Securities;
and (viii) all other costs and expenses incident to the performance of its
obligations hereunder that are not otherwise specifically provided for in this
Section.  It is understood, however, that, except as provided in this Section,
Section 8 and Section 11 hereof, the Underwriters will pay all of their own
costs and expenses, including the fees of their counsel, transfer taxes on
resale of any of the Securities by them, and any advertising expenses connected
with any offers they may make.

         7.      The obligations of the Underwriters of any Designated
Securities under the Pricing Agreement relating to such Designated Securities
shall be subject, in the discretion of the Representatives, to the condition
that all representations and warranties and other statements of the Company
herein are, at and as of the Time of Delivery for such Designated Securities,
true and correct, the condition that the Company shall have performed all of
its





                                      -9-
<PAGE>   10
obligations hereunder theretofore to be performed, and the following additional
conditions:

                 (a)      No stop order suspending the effectiveness of the
         Registration Statement shall have been issued and no proceeding for
         that purpose shall have been initiated or threatened by the
         Commission; and all requests for additional information on the part of
         the Commission shall have been complied with to the reasonable
         satisfaction of the Representatives;

                 (b)      Hughes & Luce, L.L.P., counsel for the Underwriters,
         shall have furnished to the Representatives such opinion or opinions,
         dated the Time of Delivery for such Designated Securities, concerning
         such matters as the Representatives may reasonably request, and such
         counsel shall have received such papers and information as they may
         reasonably request to enable them to pass upon such matters;

                 (c)      Raymond G. Smerge, Vice President, Chief Legal
         Officer and Secretary (as to (i) through (vi) and (ix), (xii) and
         (xiii) below) and Thompson & Knight, A Professional Corporation,
         special counsel for the Company (as to (vii), (viii), (x), (xi) and
         (xiii) below), shall have furnished to the Representatives their
         respective written opinions, dated the Time of Delivery for such
         Designated Securities, in form and substance reasonably satisfactory
         to the Representatives, to the effect that:

                   (i)     The Company has been duly incorporated and is
            validly existing as a corporation in good standing under the laws
            of the State of Nevada, with full corporate power and authority to
            own its properties and conduct its business as described in the
            Prospectus, as amended or supplemented;

                  (ii)     The Company has an authorized capitalization as set
            forth in the Prospectus, as amended or supplemented, and all of the
            outstanding shares of capital stock of the Company have been duly
            and validly authorized and issued and are fully paid and
            nonassessable;

                 (iii)     The Company has been duly qualified as a foreign
            corporation for the transaction of business and is in good standing
            under the laws of each jurisdiction in which the failure to so
            qualify would have a material adverse effect upon the Company and
            its subsidiaries, taken as a whole (such counsel being entitled to
            rely in respect of the opinion in this clause upon certificates
            issued by various state authorities as deemed necessary by such
            counsel);

                  (iv)     Each subsidiary of the Company has been duly
            incorporated and is validly existing as a corporation in good
            standing under the laws of its jurisdiction of incorporation; each
            subsidiary of the Company has been duly qualified as a foreign
            corporation for the transaction of business and is in good standing
            under the laws of each jurisdiction in which the failure to so
            qualify would have a material adverse effect upon the Company and
            its subsidiaries, taken as a whole (such counsel being entitled to
            rely in respect of the opinion in this clause upon certificates
            issued by various state authorities as deemed necessary by such
            counsel); and all of the outstanding shares of capital stock of
            each such subsidiary have been duly and validly authorized and
            issued, are fully paid and nonassessable, and (except for
            directors' qualifying





                                      -10-
<PAGE>   11
            shares and except as otherwise set forth in the Prospectus) are
            owned directly or indirectly by the Company, free and clear of all
            liens, encumbrances, equities or claims affecting transferability
            or voting;

                   (v)     To the best of such counsel's knowledge and other
            than as set forth or contemplated, or incorporated by reference, in
            the Prospectus, as amended or supplemented, there are no legal or
            governmental proceedings pending to which the Company or any of its
            subsidiaries is a party or of which any property of the Company or
            any of its subsidiaries is the subject which, if determined
            adversely to the Company or any of its subsidiaries, would
            individually or in the aggregate have a material adverse effect on
            the business, assets, financial position or prospects of the
            Company and its subsidiaries, taken as a whole; and, to the best of
            such counsel's knowledge, no such proceedings are threatened or
            contemplated by governmental authorities or threatened by others;

                  (vi)     This Agreement and the Pricing Agreement with
            respect to the Designated Securities have been duly authorized,
            executed and delivered by the Company and each constitutes a valid
            and legally binding obligation of the Company, enforceable against
            the Company in accordance with their respective terms, subject, as
            to enforcement, to bankruptcy, insolvency, reorganization and other
            laws of general applicability relating to or affecting creditors'
            rights and to general equity principles that may limit the
            availability of certain remedies (including specific performance),
            and except to the extent that rights of indemnification hereunder
            may be limited by applicable law or equity principles;

                 (vii)     The Designated Securities have been duly authorized,
            executed, authenticated, issued and delivered and constitute valid
            and legally binding obligations of the Company entitled to the
            benefits provided by the Indenture, subject, as to enforcement, to
            bankruptcy, insolvency, reorganization and other laws of general
            applicability relating to or affecting creditors' rights and to
            general equity principles that may limit the availability of
            certain remedies (including specific performance); and the
            Designated Securities and the Indenture conform in all material
            respects to the descriptions thereof in the Prospectus, as amended
            or supplemented;

                (viii)     The Indenture has been duly authorized, executed and
            delivered by the Company and constitutes a valid and legally
            binding instrument enforceable against the Company in accordance
            with its terms, subject, as to enforcement, to bankruptcy,
            insolvency, reorganization and other laws of general applicability
            relating to or affecting creditors' rights and to general equity
            principles that may limit the availability of certain remedies
            (including specific performance); and the Indenture has been duly
            qualified under the Trust Indenture Act;

                  (ix)     The issue and sale of the Designated Securities and
            the compliance by the Company with all of the provisions of the
            Designated Securities, the Indenture, and this Agreement and the
            Pricing Agreement and the consummation of the transactions herein
            and therein contemplated will not conflict with or result in a
            breach of any of the terms or provisions of, or constitute a
            default under, any indenture, mortgage,





                                      -11-
<PAGE>   12
            deed of trust, loan agreement or other agreement or instrument
            known to such counsel to which the Company or any of its
            subsidiaries is a party or by which the Company or any of its
            subsidiaries is bound or to which any of the property or assets of
            the Company or any of its subsidiaries is subject, nor will such
            action result in any violation of the provisions of the Articles of
            Incorporation, as amended or restated, or the Bylaws of the Company
            or any statute or order, rule or regulation of any court or
            governmental agency or body having jurisdiction over the Company or
            any of its subsidiaries or any of their properties;

                   (x)     To the best of such counsel's knowledge, no consent,
            approval, authorization, order, registration or qualification of or
            with any such court or governmental agency or body is required for
            the issue and sale of the Designated Securities or the consummation
            of the other transactions contemplated by this Agreement, the
            Pricing Agreement or the Indenture, except such as have been
            obtained under the Act and the Trust Indenture Act and such
            consents, approvals, authorizations, registrations or
            qualifications as may be required under state securities or Blue
            Sky laws in connection with the purchase and distribution of the
            Designated Securities by the Underwriters;

                  (xi)     The Registration Statement is effective under the
            Act, and, to the best of such counsel's knowledge, no proceedings
            for a stop order are pending or threatened under the Act;

                 (xii)     The documents incorporated by reference in the
            Prospectus, as amended or supplemented (other than the financial
            statements, statistical data and related schedules therein, as to
            which such counsel need express no opinion), when they became
            effective or were filed with the Commission, as the case may be,
            complied as to form in all material respects with the requirements
            of the Act or the Exchange Act, as applicable, and the rules and
            regulations of the Commission thereunder; and such counsel has no
            reason to believe that any of such documents, when they became
            effective or were so filed, as the case may be (other than the
            financial statements, statistical data and related schedules
            therein, as to which such counsel need express no belief),
            contained, in the case of a registration statement that became
            effective under the Act, an untrue statement of a material fact or
            omitted to state a material fact necessary in order to make the
            statements therein not misleading, and, in the case of other
            documents that were filed under the Act or the Exchange Act with
            the Commission, an untrue statement of a material fact or omitted
            to state a material fact necessary in order to make the statements
            therein, in light of the circumstances under which they were made
            when such documents were so filed, not misleading; and such counsel
            does not know of any contracts or other documents of a character
            required to be filed as an exhibit to the Registration Statement or
            required to be incorporated by reference into the Prospectus or
            required to be described in the Registration Statement or the
            Prospectus that are not filed or incorporated by reference or
            described as required; and

                (xiii)     The Registration Statement and the Prospectus (other
            than the financial statements, statistical data and related
            schedules therein, as to which such counsel need express no
            opinion), at the effective date thereof and at the Time of Delivery
            for the Designated Securities





                                      -12-
<PAGE>   13
            complied as to form in all material respects with the requirements
            of the Act and the Trust Indenture Act, as applicable, and the
            rules and regulations thereunder; such counsel has no reason to
            believe that, as of the effective date of the Registration
            Statement, the Registration Statement (other than the financial
            statements, statistical data and related schedules therein, as to
            which such counsel need express no belief) contained an untrue
            statement of a material fact or omitted to state a material fact
            required to be stated therein or necessary to make the statements
            therein not misleading or that, as of the Time of Delivery, the
            Prospectus (or, as of its date, any amendment or supplement thereto
            made by the Company prior to the Time of Delivery) (other than the
            financial statements, statistical data and related schedules
            therein, as to which such counsel need express no belief) contains
            an untrue statement of a material fact or omits to state a material
            fact necessary to make the statements therein, in light of the
            circumstances under which they were made, not misleading.

            (d)  On or as promptly as practicable after the date of the Pricing
      Agreement for such Designated Securities and at the Time of Delivery for
      such Designated Securities, Arthur Andersen LLP, who have certified the
      financial statements of the Company and its subsidiaries included or
      incorporated by reference in the Registration Statement, shall have
      furnished to the Representatives a letter, dated as of the date of such
      Pricing Agreement, and a letter dated such Time of Delivery,
      respectively, to the effect set forth in Annex II hereto, and with
      respect to such letter dated such Time of Delivery, as to such other
      matters as the Representatives may reasonably request and in form and
      substance reasonably satisfactory to the Representatives;

            (e)  (i)  Neither the Company nor any of its subsidiaries shall
      have sustained since the date of the latest audited financial statements
      included or incorporated by reference in the Prospectus, as amended or
      supplemented, any loss or interference with its business from fire,
      explosion, flood or other calamity, whether or not covered by insurance,
      or from any labor dispute or court or governmental action, order or
      decree, otherwise than as set forth or contemplated in the Prospectus, as
      amended or supplemented, and (ii) since the respective dates as of which
      information is given in the Prospectus, as amended or supplemented, there
      shall not have been any material change in the capital stock (other than
      through exercise of employee stock options) or long-term debt of the
      Company and any of its subsidiaries, taken as a whole (other than
      borrowings and repayments made in the ordinary course of business), or
      any change, or any development involving a prospective change, in or
      affecting the general affairs, management, financial position,
      stockholders' equity or results of operations of the Company and its
      subsidiaries, otherwise than as set forth or contemplated in the
      Prospectus, the effect of which, in any such case described in clause (i)
      or (ii), is in the reasonable judgment of the Representatives so material
      and adverse as to make it impracticable or inadvisable to proceed with
      the public offering or delivery of the Designated Securities on the terms
      and in the manner contemplated in the Prospectus, as amended or
      supplemented;

            (f)  Subsequent to the date of the Pricing Amendment relating to
      the Designated Securities, no downgrading shall have occurred in the
      rating accorded the Company's debt securities by any "nationally
      recognized





                                      -13-
<PAGE>   14
      statistical rating organization," as that term is defined by the
      Commission for purposes of Rule 436(g)(2) under the Act, and no notice of
      any intended or potential downgrading in such rating shall have been
      received by the Company from any such organization;

            (g)  Subsequent to the date of the Pricing Amendment relating to
      the Designated Securities, there shall not have occurred any of the
      following:  (i) a suspension or material limitation in trading in
      securities generally on the New York Stock Exchange; (ii) a general
      moratorium on commercial banking activities in New York declared by
      either federal or New York State authorities; or (iii) the engagement by
      the United States in hostilities that have resulted in the declaration,
      on or after the date of such Pricing Agreement, of a national emergency
      or war if the effect of any such event specified in this clause (iii), in
      the reasonable judgment of the Representatives, makes it impracticable or
      inadvisable to proceed with the public offering or the delivery of the
      Designated Securities on the terms and in the manner contemplated in the
      Prospectus, as amended or supplemented; and

            (h)  The Company shall have furnished or caused to be furnished to
      the Representatives at the Time of Delivery for the Designated
      Securities, certificates of officers of the Company satisfactory to the
      Representatives as to the accuracy of the representations and warranties
      of the Company herein at and as of such Time of Delivery, as to the
      performance by the Company of all of its obligations hereunder to be
      performed at or prior to such Time of Delivery, as to the matters set
      forth in subsections (a) and (e) of this Section and as to such other
      matters as the Representatives may reasonably request.

      8.    (a)  The Company will indemnify and hold harmless each Underwriter
against any losses, claims, damages or liabilities, joint or several, to which
such Underwriter may become subject, under the Act or otherwise, insofar as
such losses, claims, damages or liabilities (or actions in respect thereof)
arise out of or are based upon an untrue statement or alleged untrue statement
of a material fact contained in any Preliminary Prospectus, any preliminary
prospectus supplement, the Registration Statement or the Prospectus, as amended
or supplemented, or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, and will reimburse
each Underwriter for any legal or other expenses reasonably incurred by such
Underwriter in connection with investigating or defending any such action or
claim; provided, however, that the Company shall not be liable in any such case
to the extent that any such loss, claim, damage or liability arises out of or
is based upon an untrue statement or alleged untrue statement or omission or
alleged omission made in any Preliminary Prospectus, any preliminary prospectus
supplement, the Registration Statement or the Prospectus, as amended or
supplemented, in reliance upon and in conformity with written information
furnished to the Company by or on behalf of any Underwriter expressly for use
therein; provided further, that the Company shall not be liable to the
Underwriters under the indemnity agreement in this subsection (a) with respect
to any Preliminary Prospectus or any preliminary prospectus supplement to the
extent that any such loss, claim, damage or liability of such Underwriter
results from the fact that such Underwriter sold Securities to a person to whom
there was not sent or given, at or prior to the written confirmation of such
sale, a copy of the Prospectus or the Prospectus as





                                      -14-
<PAGE>   15
then amended or supplemented if the Company had previously furnished copies
thereof to such Underwriter.

      (b)   Each Underwriter will indemnify and hold harmless the Company
against any losses, claims, damages or liabilities to which the Company may
become subject, under the Act or otherwise, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are
based upon an untrue statement or alleged untrue statement of a material fact
contained in any Preliminary Prospectus, any preliminary prospectus supplement,
the Registration Statement or the Prospectus, as amended or supplemented, or
arise out of or are based upon the omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the
statements therein not misleading, in each case to the extent, but only to the
extent, that such untrue statement or alleged untrue statement or omission or
alleged omission was made in any Preliminary Prospectus, any preliminary
prospectus supplement, the Registration Statement or the Prospectus, as amended
or supplemented, in reliance upon and in conformity with written information
furnished to the Company by or on behalf of such Underwriter expressly for use
therein; and will reimburse the Company for any legal or other expenses
reasonably incurred by the Company in connection with investigating or
defending any such action or claim.

      (c)   Promptly after receipt by an indemnified party under subsection (a)
or (b) above of notice of the commencement of any action, such indemnified
party shall, if a claim with respect thereto is to be made against the
indemnifying party under such subsection, notify the indemnifying party in
writing of the commencement thereof; but the omission so to notify the
indemnifying party shall not relieve it from any liability that it may have to
any indemnified party otherwise than under such subsection.  In case any such
action shall be brought against any indemnified party and it shall notify the
indemnifying party of the commencement thereof, the indemnifying party shall be
entitled to participate therein and, to the extent that it shall be entitled to
participate therein and, to the extent that it shall wish, jointly with any
other indemnifying party similarly notified, to assume the defense thereof,
with counsel reasonably satisfactory to such indemnified party (who shall not,
except with the consent of the indemnified party, be counsel to the
indemnifying party), and, after notice from the indemnifying party to the such
indemnified party of its election so to assume the defense thereof, the
indemnifying party shall not be liable to such indemnified party under such
subsection for any legal expenses of other counsel or any other expenses, in
each case subsequently incurred by such indemnified party, in connection with
the defense thereof other than reasonable costs of investigation.

      (d)   If the indemnification provided for in this Section 8 is
unavailable to or insufficient to hold harmless an indemnified party under
subsection (a) or (b) above in respect of any losses, claims, damages or
liabilities (or actions in respect thereof) referred to therein, then each
indemnifying party shall contribute to the amount paid or payable by such
indemnified party as a result of such losses, claims, damages or liabilities
(or actions in respect thereof) in such proportion as is appropriate to reflect
the relative benefits received by the Company on the one hand and the
Underwriters of the Designated Securities on the other from the offering of
such Designated Securities.  If, however, the allocation provided by the
immediately preceding sentence is not permitted by applicable law, then each
indemnifying party shall contribute to such amount paid or payable by such
indemnified party in such proportion as is appropriate to reflect not only such
relative benefits but also the relative fault of the





                                      -15-
<PAGE>   16
Company on the one hand and the Underwriters of the Designated Securities on
the other in connection with the statements or omissions that resulted in such
losses, claims, damages or liabilities (or actions in respect thereof), as well
as any other relevant equitable considerations.  The relative benefits received
by the Company on the one hand and such Underwriters on the other shall be
deemed to be in the same proportion as the total net proceeds from the offering
(before deducting expenses) received by the Company bear to the total
underwriting discounts and commissions received by such Underwriters.  The
relative fault shall be determined by reference to, among other things, whether
the untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information supplied by
the Company on the one hand or such Underwriters on the other and the parties'
relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission.  The Company and the Underwriters agree
that it would not be just and equitable if contribution pursuant to this
subsection (d) were determined by pro rata allocation (even if the Underwriters
were treated as one entity for such purpose) or by any other method of
allocation that does not take account of the equitable considerations referred
to above in this subsection (d).  The amount paid or payable by an indemnified
party as a result of the losses, claims, damages or liabilities (or actions
with respect thereto) referred to above in this subsection (d) shall be deemed
to include any legal  or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any such action or claim.
Notwithstanding the provisions of this subsection (d), no Underwriter shall be
required to contribute any amount in excess of the amount by which the total
price at which the applicable Designated Securities underwritten by it and
distributed to the public were offered to the public exceeds the amount of any
damages that such Underwriter has otherwise been required to pay by reason of
such untrue or alleged untrue statement or omission or alleged omission.  No
person guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Act) shall be entitled to contribution from any person who was not
guilty of such fraudulent misrepresentation.  The obligations of the
Underwriters of Designated Securities in this subsection (d) to contribute are
several in proportion to their respective underwriting obligations with respect
to such Securities and not joint.

      (e)   The obligations of the Company under this Section 8 shall be in
addition to any liability that the Company may otherwise have and shall extend,
upon the same terms and conditions, to each person, if any, who controls any
Underwriter within the meaning of the Act; and the obligations of the
Underwriters under this Section 8 shall be in addition to any liability that
the respective Underwriters may otherwise have and shall extend, upon the same
terms and conditions, to each officer and director of the Company and to each
person, if any, who controls the Company within the meaning of the Act.

      9.    (a)  If any Underwriter shall default in its obligation to purchase
the Designated Securities that it has agreed to purchase under the Pricing
Agreement relating to such Designated Securities, the Representatives may in
their discretion arrange for themselves or another party or other parties to
purchase such Designated Securities on the terms contained herein.  If within
thirty-six hours after such default by any Underwriter, the Representatives do
not arrange for the purchase of such Designated Securities, then the Company
shall be entitled to a further period of thirty-six hours within which to
procure another party or other parties satisfactory to the Representatives to
purchase such Designated Securities on such terms.  In the event that, within
the respective





                                      -16-
<PAGE>   17
prescribed periods, the Representatives notify the Company that they have so
arranged for the purchase of such Designated Securities, or the Company
notifies the Representatives that it has so arranged for the purchase of such
Designated Securities, the Representatives or the Company shall have the right
to postpone the Time of Delivery for such Designated Securities for a period of
not more than seven days, in order to effect whatever changes may thereby be
made necessary in the Registration Statement or the Prospectus, as amended or
supplemented, or in any other documents or arrangements, and the Company agrees
to file promptly any amendments to the Registration Statement or the Prospectus
that, in the opinion of the Representatives, may thereby be made necessary.
The term "Underwriter" as used in this Agreement shall include any person
substituted under this Section with like effect as if such person had
originally been a party to this Agreement with respect to such Designated
Securities.

      (b)   If, after giving effect to any arrangements for the purchase of the
Designated Securities of a defaulting Underwriter or Underwriters by the
Representatives or the Company as provided in subsection (a) above, the
aggregate principal amount of such Designated Securities that remains
unpurchased does not exceed one-eleventh of the aggregate principal amount of
the Designated Securities, then the Company shall have the right to require
each nondefaulting Underwriter to purchase the principal amount of Designated
Securities that such Underwriter agreed to purchase under the Pricing Agreement
relating to such Designated Securities and, in addition, to require each
nondefaulting Underwriter to purchase its pro rata share (based on the
principal amount of Designated Securities that such Underwriter agreed to
purchase under such Pricing Agreement) of the Designated Securities of such
defaulting Underwriter or Underwriters for which such arrangements have not
been made; but nothing herein shall relieve a defaulting Underwriter from
liability for its default.

      (c)   If, after giving effect to any arrangements for the purchase of the
Designated Securities of a defaulting Underwriter or Underwriters by the
Representatives and the Company as provided in subsection (a) above, the
aggregate principal amount of Designated Securities that remains unpurchased
exceeds one-eleventh of the aggregate principal amount of the Designated
Securities, as referred to in subsection (b) above, or if the Company shall not
exercise the right described in subsection (b) above to require nondefaulting
Underwriters to purchase Designated Securities of a defaulting Underwriter or
Underwriters, then the Pricing Agreement relating to such Designated Securities
shall thereupon terminate, without liability on the part of any nondefaulting
Underwriter or the Company, except for the expenses to be borne by the Company
and the Underwriters as provided in Section 6 hereof and the indemnity and
contribution agreements in Section 8 hereof; but nothing herein shall relieve a
defaulting Underwriter from liability for its default.

      10.   The respective indemnities, agreements, representations, warranties
and other statements of the Company and the several Underwriters, as set forth
in this Agreement or made by or on behalf of them, respectively, pursuant to
this Agreement, shall remain in full force and effect, regardless of any
investigation (or any statement as to the results thereof) made by or on behalf
of any Underwriter or any controlling person of any Underwriter, or the
Company, or any officer or director or controlling person of the Company, and
shall survive delivery of and payment for the Securities.

      11.   If any Pricing Agreement shall be terminated pursuant to Section 9
hereof, the Company shall not then be under any liability to any Underwriter
with





                                      -17-
<PAGE>   18
respect to the Designated Securities covered by such Pricing Agreement except
as provided in Section 6 and Section 8 hereof; but, if for any other reason
Designated Securities are not delivered by or on behalf of the Company as
provided herein, the Company will reimburse the Underwriters through the
Representatives for all out-of-pocket expenses approved in writing by the
Representatives, including fees and disbursements of counsel, reasonably
incurred by the Underwriters in making preparations for the purchase, sale and
delivery of such Designated Securities, but the Company shall then be under no
further liability to any Underwriter with respect to such Designated Securities
except as provided in Section 6 and Section 8 hereof; and further provided,
however, that notwithstanding the foregoing, the Company shall have no
obligation to reimburse the Underwriters as described above if Designated
Securities are not delivered by or on behalf of the Company as provided herein
because of the failure of counsel for the Underwriters to furnish the opinion
or opinions contemplated by Section 7(b) hereof, or because of the occurrence
of any of the events described in Section 7(f) or (g) hereof.  The Company
shall not in any event be liable to any Underwriter for loss of anticipated
profits from the transactions contemplated by this Agreement, the Pricing
Agreement or otherwise.

      12.   In all dealings hereunder, the Representatives shall act on behalf
of each of the Underwriters, and the parties hereto shall be entitled to act
and rely upon any statement, request, notice or agreement on behalf of any
Underwriter made or given by such Representatives jointly or by such of the
Representatives, if any, as may be designated for such purpose in the Pricing
Agreement.

      All statements, requests, notices and agreements hereunder shall be in
writing or by telegram if promptly confirmed in writing, and if to the
Underwriters shall be sufficient in all respects if delivered or sent by
registered mail to the address of the Representatives, as set forth in the
Pricing Agreement; and if to the Company shall be sufficient in all respects if
delivered or sent by registered mail to the address of the Company set forth in
the Registration Statement, Attention:  Vice President, Chief Legal Officer and
Secretary; provided, however, that any notice to an Underwriter pursuant to
Section 8(c) hereof shall be delivered or sent by registered mail to such
Underwriter at its address set forth in its Underwriters' Questionnaire, or
telex constituting such Questionnaire, which address will be supplied to the
Company by the Representatives upon request.

      13.   This Agreement and each Pricing Agreement shall be binding upon,
and inure solely to the benefit of, the Underwriters, the Company and, to the
extent provided in Section 8 and Section 10 hereof, the officers and directors
of the Company and each person who controls the Company or any Underwriter, and
their respective heirs, executors, administrators, successors and assigns, and
no other person shall acquire or have any rights under or by virtue of this
Agreement or any Pricing Agreement.  No purchaser of any of the Securities from
any Underwriter shall be deemed a successor or assign by reason merely of such
purchase.

      14.   Time shall be of the essence of this Agreement.

      15.   This Agreement and each Pricing Agreement shall be construed in
accordance with the laws of the State of Texas.





                                      -18-
<PAGE>   19
        16.   This Agreement and each Pricing Agreement may be executed by any
one or more of the parties hereto and thereto in any number of counterparts,
each of which shall be deemed to be an original, but all such respective
counterparts shall together constitute one and the same instrument.

        If the foregoing is in accordance with your understanding, please sign
and return to us two (2) counterparts hereof.

                                                           
                                               Very truly yours,

                                               CENTEX CORPORATION

                                                            
                                               By:/S/ VICKI A. ROBERTS   
                                                  ----------------------------
                                                      Vicki A. Roberts,
                                                          Treasurer


Accepted as of the date hereof
at Dallas, Texas:

NATIONSBANC CAPITAL MARKETS, INC.



By: /S/ STUART B. GLEICHENHAUS                                 
   ---------------------------------
        Stuart B. Gleichenhaus,
   Senior Vice President and Director





                                      -19-
<PAGE>   20
                                                                         ANNEX I


                               PRICING AGREEMENT



[Name and address of Representative(s)]


                                                       _________________, 199___


Dear Sirs:

      Centex Corporation (the "Company") proposes, subject to the terms and
conditions stated herein and in the Underwriting Agreement, dated June 5, 1995
(the "Underwriting Agreement"), to issue and sell to the Underwriters named in
Schedule I hereto (the "Underwriters") the Securities specified in Schedule II
hereto (the "Designated Securities").  Each of the provisions of the
Underwriting Agreement is incorporated herein by reference in its entirety, and
shall be deemed to be part of this Pricing Agreement to the same extent as if
such provisions had been set forth in full herein, and each of the
representations and warranties set forth therein shall be deemed to have been
made at and as of the date of this Pricing Agreement, except that each
representation and warranty with respect to the Prospectus in Section 2 of the
Underwriting Agreement shall be deemed to be a representation or warranty as of
the date of the Underwriting Agreement in relation to the Prospectus (as
therein defined), and also a representation and warranty as of the date of this
Pricing Agreement in relation to the Prospectus, as amended or supplemented,
relating to the Designated Securities that are the subject of this Pricing
Agreement.  Each reference to the Representatives herein and in the provisions
of the Underwriting Agreement so incorporated by reference shall be deemed to
refer to you.  Unless otherwise defined herein, terms defined in the
Underwriting Agreement are used herein as therein defined.  The Representatives
designated to act on behalf of the Representatives and on behalf of each of the
Underwriters of the Designated Securities pursuant to Section 12 of the
Underwriting Agreement and the address of the Representatives referred to in
such Section 12 are set forth at the end of Schedule II hereto.

      An amendment to the Registration Statement, or a supplement to the
Prospectus, as the case may be, relating to the Designated Securities, in the
form heretofore delivered to you is now proposed to be filed, or in the case of
a supplement, transmitted for filing, with the Commission.

      Subject to the terms and conditions set forth herein and in the
Underwriting Agreement incorporated herein by reference, the Company agrees to
issue and sell to each of the Underwriters, and each of the Underwriters
agrees, severally and not jointly, to purchase from the Company, at the time
and place and at the purchase price to the Underwriters set forth in Schedule
II hereto, the principal amount of Designated Securities set forth opposite the
name of such Underwriter in Schedule I hereto.

      If the foregoing is in accordance with your understanding, please sign
and return to us two (2) counterparts hereof, and upon acceptance hereof by
you, on behalf of each of the Underwriters, this Pricing Agreement and such
acceptance hereof, including the provisions of the Underwriting Agreement
incorporated
<PAGE>   21
herein by reference, shall constitute a binding agreement between each of the
Underwriters and the Company.  It is understood that your acceptance of this
Pricing Agreement on behalf of each of the Underwriters is or will be pursuant
to the authority set forth in a form of Agreement among Underwriters, the form
of which shall be submitted to the Company for examination, upon request, but
without warranty on the part of the Representatives as to the authority of the
signers thereof.

                                         Very truly yours,
                                  
                                         CENTEX CORPORATION
                                  
                                  
                                  
                                         By:   ______________________________
                                  

                                         Name: ______________________________
                                     
                                  
                                         Title:______________________________
                                  



Accepted as of the date hereof
at Dallas, Texas:

[Name and address of Representative(s)]

By: ___________________________________

    ___________________________________





                                      -2-
<PAGE>   22
                                  SCHEDULE I


<TABLE>
<CAPTION>
                                                       Principal
                                                       Amount of
                                                      Securities
                                                         to be
   Underwriter                                         Purchased
   -----------                                         ---------
<S>                                                   <C>
                                                      $
                                                                  







                                                      ------------
                                                                  
Total . . . . . . . . . . . . . . . . . .             $                   
                                                      ============
                                                                  
</TABLE>


                                      -3-
<PAGE>   23
                                  SCHEDULE II

Title of Designated Securities:

      [____]%
      [Subordinated Debt Securities] due ____________


Aggregate principal amount:

      $__________________


Price to Public:

      % of the principal amount of the Designated Securities,
      plus accrued interest from ___________ to ____________ [and accrued
      amortization, if any, from ___________ to ____________]


Purchase Price by Underwriters:

      [____]% of the principal amount of the Designated Securities,
      plus accrued interest from ___________ to ____________ [and accrued
      amortization, if any, from ___________ to ____________]


Specified funds for payment of purchase price:

      Wire transfer of immediately available funds


Indenture:

      Indenture, dated as of March 12, 1987, between the Company and Texas
      Commerce Bank National Association, as Trustee


Maturity:


Interest Rate:
      [_____]%

Interest Payment Dates:
      [months and dates]


Redemption Provisions:
      [Provisions for redemption]


Sinking Fund Provisions:





                                      -4-
<PAGE>   24
      [The Designated Securities are entitled to the benefit of a sinking fund
      to retire $________ principal amount of Designated Securities on
      _____________ in each of the years _____ through _______ at 100% of their
      principal amount plus accrued interests] [, together with [cumulative]
      [noncumulative] redemptions at the option of the Company to retire an
      additional $__________________ principal amount of Designated Securities
      in the years _______ through ______ at 100% of their principal amount
      plus accrued interest].


Time of Delivery:


Closing Location:


Name and address of Representatives:

      Designated Representatives:



      Address for Notices, etc.:


Book-Entry Provisions:

      [Provisions for book-entry registration
       of the Designated Securities]


[Other terms]:





                                      -5-
<PAGE>   25
                                                                        ANNEX II


                         DESCRIPTION OF COMFORT LETTER

      Pursuant to Section 7(d) of the Underwriting Agreement, the accountants
shall furnish letters to the Underwriters to the effect that:

               (i)   They are independent certified public accountants with
      respect to the Company and its subsidiaries within the meaning of the Act
      and the applicable published rules and regulations thereunder;

              (ii)   In their opinion, the financial statements and any
      supplementary financial information and schedules examined by them and
      included or incorporated by reference in the Registration Statement or
      the Prospectus comply as to form in all material respects with the
      applicable accounting requirements of the Act or the Exchange Act, as
      applicable, and the related published rules and regulations thereunder;
      and, if applicable, they have made a review in accordance with standards
      established by the American Institute of Certified Public Accountants of
      the consolidated interim financial statements, selected financial data,
      pro forma financial information and/or condensed financial statements
      derived from audited financial statements of the Company for the periods
      specified in such letter, as indicated in their reports thereon, copies
      of which have been furnished to the representatives of the Underwriters
      (the "Representatives");

             (iii)   In their opinion, the unaudited selected financial
      information with respect to the consolidated results of operations and
      financial position of the Company for the five most recent fiscal years
      included in the Prospectus and included or incorporated by reference in
      Item 6 of the Company's Annual Report on Form 10-K for the most recent
      fiscal year agrees with the corresponding amounts (after restatement
      where applicable) in the audited consolidated financial statements for
      such five fiscal years that were included or incorporated by reference in
      the Company's Annual Reports on Form 10-K for such fiscal years;

              (iv)   On the basis of limited procedures, not constituting an
      examination in accordance with generally accepted auditing standards,
      consisting of a reading of the unaudited financial statements and other
      information referred to below, a reading of the latest available interim
      financial statements of the Company and its subsidiaries, inspection of
      the minute books of the Company and its subsidiaries since the date of
      the latest audited financial statements included or incorporated by
      reference in the Prospectus, inquiries of officials of the Company and
      its subsidiaries responsible for financial and accounting matters and
      such other inquiries and procedures as may be specified in such letter,
      nothing came to their attention that caused them to believe that:

                     (A)   the unaudited condensed consolidated statements of
               income, consolidated balance sheets and consolidated statements
               of changes in financial position included or incorporated by
               reference in the Company's Quarterly Reports on Form 10-Q
               incorporated by reference in the Prospectus do not comply as to
               form in all material respects with the applicable accounting
               requirements of the Exchange Act as it





                                      -1-
<PAGE>   26
               applies to Form 10-Q and the related published rules and
               regulations thereunder or are not in conformity with generally
               accepted accounting principles applied on a basis substantially
               consistent with the basis for the audited consolidated
               statements of income, consolidated balance sheets and
               consolidated statements of changes in financial position
               included or incorporated by reference in the Company's Annual
               Report on Form 10-K for the most recent fiscal year;

                     (B)   any other unaudited income statement data and
               balance sheet items included in the Prospectus do not agree with
               the corresponding items in the unaudited consolidated financial
               statements from which such data and items were derived, and any
               such unaudited data and items were not determined on a basis
               substantially consistent with the basis for the corresponding
               amounts in the audited consolidated financial statements
               included or incorporated by reference in the Company's Annual
               Report on Form 10-K for the most recent fiscal year;

                     (C)   the unaudited financial statements that were not
               included in the Prospectus but from which were derived the
               unaudited condensed financial statements referred to in clause
               (A) and any unaudited income statement data and balance sheet
               items included in the Prospectus and referred to in clause (B)
               were not determined on a basis substantially consistent with the
               basis for the audited financial statements included or
               incorporated by reference in the Company's Annual Report on Form
               10-K for the most recent fiscal year;

                     (D)   any unaudited pro forma consolidated condensed
               financial statements included or incorporated by reference in
               the Prospectus do not comply as to form in all material respects
               with the applicable accounting requirements of the Act and the
               published rules and regulations thereunder or the pro forma
               adjustments have not been properly applied to the historical
               amounts in the compilation of those statements;

                     (E)   as of a specified date not more than five days prior
               to the date of such letter, there have been any changes in the
               consolidated capital stock (other than issuances of capital
               stock upon exercise of options and stock appreciation rights,
               upon earn-outs of performance shares and upon conversions of
               convertible securities, in each case that were outstanding on
               the date of the latest balance sheet included or incorporated by
               reference in the Prospectus) or any increase in the consolidated
               long-term debt of the Company and its subsidiaries, or any
               decreases in consolidated net current assets or net assets or
               other items specified by the Representatives, or any increases
               in any items specified by the Representatives, in each case as
               compared with amounts shown in the latest balance sheet included
               or included or incorporated by reference in the Prospectus,
               except in each case for changes, increases or decreases that the
               Prospectus discloses have occurred or may occur or that are
               described in such letter; and

                     (F)   for the period from the date of the latest financial
               statements included or incorporated by reference in the
               Prospectus to the specified date referred to in clause (E),
               there were any decreases in consolidated net revenues or
               operating profit or the total or per share amounts of
               consolidated net income or other items specified by





                                      -2-
<PAGE>   27
               the Representatives, or any increases in any items specified by
               the Representatives, in each case as compared with the
               comparable period of the preceding year and with any other
               period of corresponding length specified by the Representatives,
               except in each case for increases or decreases that the
               Prospectus discloses have occurred or may occur or that are
               described in such letter; and

               (v)   In addition to the examination referred to in their
      report(s) included or incorporated by reference in the Prospectus and the
      limited procedures, inspection of minute books, inquiries and other
      procedures referred to in paragraphs (iii) and (iv) above, they have
      carried out certain specified procedures, not constituting an examination
      in accordance with generally accepted auditing standards, with respect to
      certain amounts, percentages and financial information specified by the
      Representatives that are derived from the general accounting records of
      the Company and its subsidiaries, which appear in the Prospectus
      (excluding documents incorporated by reference) or in Part II of, or in
      exhibits and schedules to, the Registration Statement specified by the
      Representatives or in documents incorporated by reference in the
      Prospectus specified by the Representatives, and have compared certain of
      such amounts, percentages and financial information with the accounting
      records of the Company and its subsidiaries and have found them to be in
      agreement.

      All references in this Annex II to the Prospectus shall be deemed to
refer to the Prospectus (including the documents incorporated by reference
therein) as defined in the Underwriting Agreement as of the date of the letter
delivered on the date of the Pricing Agreement for purposes of such letter and
to the Prospectus as amended or supplemented (including the documents
incorporated by reference therein) in relation to the applicable Designated
Securities for purposes of the letter delivered at the Time of Delivery for
such Designated Securities.





                                      -3-

<PAGE>   1

                                                                    EXHIBIT 1(b)

                               PRICING AGREEMENT





NationsBanc Capital Markets, Inc.
901 Main Street
66th Floor
Dallas, Texas  75202


                                                                    June 5, 1995


Dear Sirs:

      Centex Corporation (the "Company") proposes, subject to the terms and
conditions stated herein and in the Underwriting Agreement, dated June 5, 1995
(the "Underwriting Agreement"), to issue and sell to the Underwriters named in
Schedule I hereto (the "Underwriters") the Securities specified in Schedule II
hereto (the "Designated Securities").  Each of the provisions of the
Underwriting Agreement is incorporated herein by reference in its entirety, and
shall be deemed to be part of this Pricing Agreement to the same extent as if
such provisions had been set forth in full herein, and each of the
representations and warranties set forth therein shall be deemed to have been
made at and as of the date of this Pricing Agreement, except that each
representation and warranty with respect to the Prospectus in Section 2 of the
Underwriting Agreement shall be deemed to be a representation or warranty as of
the date of the Underwriting Agreement in relation to the Prospectus (as
therein defined), and also a representation and warranty as of the date of this
Pricing Agreement in relation to the Prospectus, as amended or supplemented,
relating to the Designated Securities that are the subject of this Pricing
Agreement.  Each reference to the Representatives herein and in the provisions
of the Underwriting Agreement so incorporated by reference shall be deemed to
refer to you.  Unless otherwise defined herein, terms defined in the
Underwriting Agreement are used herein as therein defined.  The Representatives
designated to act on behalf of the Representatives and on behalf of each of the
Underwriters of the Designated Securities pursuant to Section 12 of the
Underwriting Agreement and the address of the Representatives referred to in
such Section 12 are set forth at the end of Schedule II hereto.

      An amendment to the Registration Statement, or a supplement to the
Prospectus, as the case may be, relating to the Designated Securities, in the
form heretofore delivered to you is now proposed to be filed, or in the case of
a supplement, transmitted for filing, with the Commission.

      Subject to the terms and conditions set forth herein and in the
Underwriting Agreement incorporated herein by reference, the Company agrees to
issue and sell to each of the Underwriters, and each of the Underwriters
agrees, severally and not jointly, to purchase from the Company, at the time
and place and at the purchase price to the Underwriters set forth in Schedule
II hereto, the principal amount of Designated Securities set forth opposite the
name of such Underwriter in Schedule I hereto.

      If the foregoing is in accordance with your understanding, please sign
and return to us two (2) counterparts hereof, and upon acceptance hereof by
you, on behalf of each of the Underwriters, this Pricing Agreement and such
acceptance hereof, including the provisions of the Underwriting Agreement
incorporated herein by reference, shall constitute a binding agreement between
each of the Underwriters and the Company.  It is understood that your
acceptance of this Pricing Agreement on behalf of each of the Underwriters is
or will be pursuant
<PAGE>   2
the authority set forth in a form of Agreement among Underwriters, the form
of which shall be submitted to the Company for examination, upon request, but
without warranty on the part of the Representatives as to the authority of the
signers thereof.


                                                            
                                              Very truly yours,

                                              CENTEX CORPORATION



                                              By:/s/ VICKI A. ROBERTS        
                                              --------------------------
                                                 Vicki A. Roberts,
                                                 Treasurer



Accepted as of the date hereof
at Dallas, Texas:

NATIONSBANC CAPITAL MARKETS, INC.



By:/S/ STUART B. GLEICHENHAUS                               
   -------------------------------------
     Stuart B. Gleichenhaus,
     Senior Vice President and Director




                                     -2-



<PAGE>   3
                                   SCHEDULE I

<TABLE>
<CAPTION>

                                                                                         Principal
                                                                                         Amount of
                                                                                         Securities
                                                                                           to be
   Underwriter                                                                           Purchased
   -----------                                                                           ---------

<S>                                                                                     <C>
NationsBanc Capital Markets, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . $100,000,000
                                                                                                    
                                                                                        ------------

Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $100,000,000
                                                                                        ============
</TABLE>
<PAGE>   4
                                  SCHEDULE II

Title of Designated Securities:

      7-3/8% Subordinated Debentures due June 1, 2005


Aggregate principal amount:

      $100,000,000


Price to Public:

      99.511% of the principal amount of the Designated Securities,
      plus accrued interest from June 9, 1995


Purchase Price by Underwriters:

      98.911% of the principal amount of the Designated Securities,
      plus accrued interest from June 9, 1995


Specified funds for payment of purchase price:

      Wire transfer of immediately available funds


Indenture:

      Indenture, dated as of March 12, 1987, between the Company and Texas
      Commerce Bank National Association, as Trustee


Maturity:

      June 1, 2005


Interest Rate:

      7-3/8%


Interest Payment Dates:

      June 1 and December 1, commencing December 1, 1995


Redemption Provisions:

      The Designated Securities are not subject to redemption
      prior to maturity.
<PAGE>   5
Sinking Fund Provisions:

      None


Time of Delivery:

      10:00 a.m., eastern time, on June 9, 1995


Closing Location:

      Offices of Thompson & Knight, P.C., 1700 Pacific Avenue, 
      Dallas, Texas 75201


Name and address of Representative(s):

      Designated Representative(s):     NationsBanc Capital Markets, Inc.


      Address for Notices, etc.:        901 Main Street
                                        66th Floor
                                        Dallas, Texas  75202


Book-Entry Provisions:

      The Designated Securities will be evidenced by a book-entry on the
      records of The Depository Trust Company, acting as custodial agent for
      brokerage firms that maintain accounts for their respective customers,
      and in such amounts as contained in instructions delivered by the
      Representative to the Company two business days prior to the Closing.
      The Representative may inspect and confirm such book-entry and custodial
      arrangements on the business day prior to the Closing.





                                      -2-

<PAGE>   1

                                                                    EXHIBIT 4(b)





                               CENTEX CORPORATION

                                     Issuer

                                      and

                    TEXAS COMMERCE BANK NATIONAL ASSOCIATION

                                    Trustee

                              INDENTURE SUPPLEMENT

                            Dated as of June 9, 1995

                                       to
                                   INDENTURE

                           Dated as of March 12, 1987

                                  $100,000,000

                7-3/8% SUBORDINATED DEBENTURES DUE JUNE 1, 2005
<PAGE>   2
         INDENTURE SUPPLEMENT, dated as of June 9, 1995, between CENTEX
CORPORATION, a Nevada corporation (together with its successors and assigns as
provided in the Indenture referred to below, the "Company"), and TEXAS COMMERCE
BANK NATIONAL ASSOCIATION, a national banking association (together with its
successors in trust thereunder as provided in the Indenture referred to below,
the "Trustee"), as trustee under an Indenture dated as of March 12, 1987 (the
"Indenture").

                             PRELIMINARY STATEMENT

         Section 2.02 of the Indenture provides, among other things, that the
Company may, when authorized by its Board of Directors, and the Trustee may at
any time and from time to time, enter into an indenture supplemental to the
Indenture for the purpose of authorizing a Series of Subordinated Debt
Securities and to specify certain terms of such Series of Subordinated Debt
Securities.  The Board of Directors of the Company has duly authorized the
creation of a Series of Subordinated Debt Securities with an aggregate
principal amount of $100,000,000 to be known as the Company's 7-3/8%
Subordinated Debentures due June 1, 2005 (the "Debentures"), and the Company
and the Trustee are executing and delivering this Indenture Supplement in order
to provide for the issuance of the Debentures.  All terms used in this
Indenture Supplement which are defined in the Indenture, either directly or by
reference therein, have the meanings assigned to them therein, except to the
extent such terms are defined in this Indenture Supplement or the context
clearly requires otherwise.

SECTION 1.       Designation.

         The Debentures shall be designated as the Company's "7-3/8%
Subordinated Debentures due June 1, 2005".

SECTION 2.       Date of Debentures.

         The Debentures which are authenticated and delivered by the Trustee to
or upon the order of the Company on the Closing Date for the Debentures shall
be dated June 9, 1995.  All other Debentures which are authenticated after the
Closing Date for the Debentures for any other purpose under the Indenture shall
be dated the date of their authentication.  For purposes of this Section 2,
"Closing Date for the Debentures" shall mean the date on which the Debentures
are first executed, authenticated and delivered.

SECTION 3.       Aggregate Principal Amount.

         The aggregate principal amount of Debentures that may be authenticated
and delivered under the Indenture and this Indenture Supplement is limited to
$100,000,000, except for Debentures authenticated and delivered upon
registration of transfer of, or in exchange for, or in lieu of, other
Debentures pursuant to Section 2.06, 2.07, 2.08 or 11.04 of the Indenture.

SECTION 4.       Interest Rate.

         The Debentures shall bear interest at the rate of 7-3/8% per annum.





                                      -1-
<PAGE>   3
SECTION 5.  Interest Payment Dates.

         The interest payment dates for the Debentures are June 1 and December
1 in each year, commencing December 1, 1995.

SECTION 6.  Record Date.

         The record date with respect to an interest payment date shall be the
close of business on the 15th day of the calendar month preceding the month in
which such interest payment date falls, or in the case of defaulted interest,
the close of business on any special record date.

SECTION 7.  Denominations of Debentures.

         The Debentures are issuable initially in denominations of $100,000 and
in integral multiples of $5,000 above such amount.  Thereafter, upon
reregistration, exchange or transfer, the Debentures are issuable in
denominations of $1,000 and integral multiples thereof.

SECTION 8.  Currency of Issuance and Payments.

         The Debentures shall be issued in the currency of United States of
America and shall be paid in such coin or currency.

SECTION 9.  No Redemption.

         Prior to maturity, the Debentures will not be redeemable at the option
of the Company or otherwise.

SECTION 10. No Sinking Fund.

         No Sinking Fund will be established with respect to the Debentures and
the Debentures will not be subject to any sinking fund payments by the Company.

SECTION 11. Form of Debentures.

         The Debentures shall be in the form attached hereto as Exhibit A.

SECTION 12. Maturity.

         The Debentures will mature and be payable in accordance with their
terms on June 1, 2005.


SECTION 13. Interest Accrual Matters.

         Interest on the Debentures shall accrue from June 9, 1995, and shall
be computed based on a 360-day year comprised of twelve 30-day months.





                                      -2-
<PAGE>   4
SECTION 14.  Book-Entry Matters.

         Pursuant to Section 2.02 of the Indenture, the following provisions
shall apply to the Debentures, notwithstanding anything to the contrary in the
Indenture:

                 (a)      The Debentures will be issued in fully registered
         form only.  However, except as provided in paragraphs (d), (e) and (f)
         of this Section 14, the registered owner of all of the Debentures
         initially shall be The Depository Trust Company ("DTC") or its
         nominee, and such Debentures initially shall be registered in the name
         of DTC or its nominee.  Payment of the principal of or interest on
         Debentures registered in the name of DTC or its nominee shall be made
         in the manner and at the address(es) specified in the Letter of
         Representations, dated June 9, 1995, from the Company and the Trustee
         to DTC, a copy of which is attached hereto as Exhibit B.  DTC (and any
         successor securities depository) and its (or their) participating
         institutions (collectively "Participants") shall maintain a book-entry
         registration and transfer system with respect to ownership of
         beneficial interests in the Debentures (the "Book-Entry System").

                 (b)      The Debentures shall be initially issued in the form
         of a separate, single, authenticated, fully registered Debenture (the
         "Global Debenture") which (i) pursuant to Section 2.01 of the
         Indenture, need not be in the form of a lithographed or engraved
         certificate, but may be typewritten or printed on ordinary paper or
         such paper as the Trustee may reasonably request, (ii) shall represent
         and be denominated in an amount equal to 100% of the aggregate
         principal amount of the Debentures issued under this Indenture
         Supplement, (iii) shall be executed by the Company and authenticated
         by the Trustee in accordance with the provisions of the Indenture, and
         delivered by the Trustee to DTC or its nominee, (iv) shall be
         registered in the Subordinated Debt Security Register in the name of
         Cede & Co., as nominee of DTC, and (v) shall contain the following
         legend on the face thereof:

                 Unless this Debenture is presented by an authorized
                 representative of The Depository Trust Company, a New York
                 corporation ("DTC"), to the Company or its agent for
                 registration of transfer, exchange or payment, and any
                 certificate issued is registered in the name of Cede & Co. or
                 in such other name as is requested by an authorized
                 representative of DTC (and any payment is made to Cede & Co.
                 or to such other entity as is requested by an authorized
                 representative of DTC), ANY TRANSFER, PLEDGE OR OTHER USE
                 HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
                 inasmuch as the registered holder hereof, Cede & Co., has an
                 interest herein.

         Unless and until it is exchanged in whole or in part for Debentures in
         definitive certificated form, the Global Debenture representing the
         Debentures may not be transferred except as a whole by DTC to a
         nominee of DTC or by a nominee of DTC to DTC or another nominee of DTC
         or by DTC or any such nominee to a successor securities depository or
         a nominee of any such successor securities depository.





                                      -3-
<PAGE>   5
                 (c)      The Trustee and the Company may treat DTC or its
         nominee, or any successor securities depository or nominee thereof
         (collectively, the "Depository"), as the sole and exclusive owner of
         the Debentures registered in its name for the purposes of payment of
         the principal of or interest on the Debentures, giving any notice
         permitted or required to be given to holders of the Debentures under
         the Indenture or this Indenture Supplement, registering the transfer
         of the Debentures, obtaining any consent or other action to be taken
         by holders of the Debentures and for all other purposes whatsoever,
         and neither the Trustee nor the Company shall be affected by any
         notice to the contrary.  Neither the Company nor the Trustee shall
         have any responsibility or obligation to any Participant, any person
         claiming a beneficial ownership interest in the Debentures under or
         through the Depository or any Participant, or any other person which
         is not shown on the Subordinated Debt Security Register as being a
         holder of the Debentures, with respect to (i) the accuracy of any
         records maintained by the Depository or any Participant; (ii) the
         payment by the Depository to any Participant of any amount in respect
         of the principal of or interest on the Debentures, or (iii) the
         payment by any Participant to any owner of a beneficial ownership
         interest in the Debentures in respect of the principal of or interest
         on the Debentures.  The Trustee shall pay all principal of and
         interest on the Debentures only to or upon the order of the registered
         holder or holders of the Debentures, as shown in the Subordinated Debt
         Security Register, and all such payments shall be valid and effective
         to fully satisfy and discharge the Company's obligations with respect
         to the principal of and interest on the Debentures to the extent of
         the sum or sums so paid.  No person other than a holder of the
         Debentures, as shown in the Subordinated Debt Security Register, shall
         receive an authenticated Debenture evidencing the obligation of the
         Company to make payment of the principal of and interest on the
         Debentures pursuant to the Indenture and this Indenture Supplement.
         Upon delivery by DTC to the Trustee of written notice to the effect
         that DTC has determined to substitute a new nominee for Cede & Co.,
         and subject to the provisions of the Indenture and this Indenture
         Supplement, the word "Cede & Co.", as used in this Indenture
         Supplement, shall refer to each new nominee of DTC.

                 (d)      In the event that after the occurrence of an Event of
         Default that has not been cured or waived, holders of a majority in
         aggregate principal amount of the beneficial interests in the
         Debentures, as reflected in the books and records of the Depository,
         notify the Trustee, through the Depository or any Participant, that
         the continuation of the Book-Entry System is no longer in the best
         interests of such holders of beneficial interests in the Debentures,
         then the Trustee shall notify the Depository and the Company, and the
         Depository will notify the Participants of the availability through
         the Depository of definitive certificated Debentures.  In such event,
         the Company shall execute, and the Trustee, upon receipt of a written
         order of the Company, signed by its President or a Vice President and
         by its Treasurer, Assistant Treasurer, Secretary or Assistant
         Secretary (an "Issuer Order"), for the authentication and delivery of
         definitive certificated Debentures, will authenticate and deliver
         Debentures in definitive certificated form, in any authorized
         denominations, all pursuant to the provisions of the Indenture, to the
         person or persons specified to the Trustee in writing by the
         Depository in the aggregate principal amount of the Global Debenture
         and in exchange for such Global Debenture.





                                      -4-
<PAGE>   6
                 (e)      If at any time the Depository notifies the Company
         that it is unwilling or unable to continue as Depository for the
         Debentures or if at any time the Depository shall no longer be
         registered as a clearing agency in good standing under the Securities
         Exchange Act of 1934, as amended, or other applicable statute or
         regulation, the Company shall appoint a successor Depository with
         respect to the Debentures.  If a successor Depository for the
         Debentures is not appointed by the Company within 90 days after the
         Company receives such notice or becomes aware of such condition, the
         Company will execute, and the Trustee, upon receipt of an Issuer Order
         for the authentication and delivery of definitive certificated
         Debentures, will authenticate and deliver Debentures in definitive
         certificated form, in any authorized denominations, all pursuant to
         the provisions of the Indenture, to the person or persons specified to
         the Trustee in writing by the Depository in the aggregate principal
         amount of the Global Debenture and in exchange for such Global
         Debenture.

                 (f)      The Company may at any time and in its sole
         discretion determine that the Debentures shall no longer be
         represented by a Global Debenture.  In such event the Company will
         execute, and the Trustee, upon receipt of an Issuer Order for the
         authentication and delivery of definitive certificated Debentures,
         will authenticate and deliver Debentures in definitive certificated
         form, in any authorized denominations, all pursuant to the provisions
         of the Indenture, to the person or persons specified to the Trustee in
         writing by the Depository in the aggregate principal amount of the
         Global Debenture and in exchange for such Global Debenture.

                 (g)      Upon the exchange of a Global Debenture for
         Debentures in definitive certificated form, in authorized
         denominations, such Global Debenture shall be cancelled by the
         Trustee.

                 (h)      Whenever the Depository requests the Company and the
         Trustee to do so, the Trustee and the Company will cooperate with the
         Depository in taking appropriate action after reasonable notice to (i)
         make available one or more separate Global Debentures evidencing the
         Debentures to any Participant having Debentures credited to its
         account at the Depository, or (ii) arrange for another Depository to
         maintain custody of the Global Debenture or Debentures evidencing the
         Debentures.

                 (i)      In connection with any notice or other communication
         to be provided to holders of the Debentures pursuant to the Indenture
         and this Indenture Supplement by the Company or the Trustee with
         respect to any consent or other action to be taken by holders of the
         Debentures, the Company or the Trustee, as the case may be, shall
         establish a record date for such consent or other action and give the
         Depository notice of such record date not less than 15 calendar days
         in advance of such record date to the extent possible.  Such notice to
         the Depository shall be given only so long as a Depository or its
         nominee is the sole holder of the Debentures.





                                      -5-
<PAGE>   7
SECTION 15. Counterparts.

         This Indenture Supplement may be executed in any number of
counterparts, each of which shall be an original; but such counterparts shall
together constitute but one and the same instrument.

SECTION 16. Governing Law.

         This Indenture Supplement and each Debenture issued hereunder shall be
deemed to be a contract made under the laws of the State of Texas, and for all
purposes shall be construed in accordance with the laws of said State.

SECTION 17. Acceptance of Trusts.

         Texas Commerce Bank National Association hereby accepts the trusts in
this Indenture Supplement declared and provided, upon the terms and conditions
herein and in the Indenture set forth.

SECTION 18. Ratification of Indenture.

         As supplemented by this Indenture Supplement, the Indenture is in all
respects ratified and confirmed and the Indenture as so supplemented by this
Indenture Supplement shall be read, taken and construed as one and the same
instrument.



                 [Remainder of page intentionally left blank.]





                                      -6-
<PAGE>   8
         IN WITNESS WHEREOF, the Company and the Trustee have caused this
Indenture Supplement to be duly executed by their respective officers thereunto
duly authorized and their respective seals duly attested to be hereunto affixed
all as of the day and year first above written.


                                    CENTEX CORPORATION
                                   
[SEAL]                             
                                   
                                   
Attest:                             By: /S/ VICKI A. ROBERTS          
                                    ----------------------------------------
                                            Vicki A. Roberts, Treasurer    
                                   
/S/ DAVID A. GREENBLATT            
- --------------------------         
David A. Greenblatt,               
Assistant Secretary                
                                    TEXAS COMMERCE BANK NATIONAL 
                                    ASSOCIATION, as Trustee
                                   
[SEAL]                             
                                   
                                   
Attest:                             By:/S/ JOANNE K. GULLIVER   
                                    ------------------------------------------
                                           JoAnne K. Gulliver, Vice President 
                                           and Trust Officer
                                   
/S/ WAYNE MENTZ                    
- --------------------------
Name:  Wayne Mentz
Title: Asst. Vice President and
       Trust Officer





                                      -7-
<PAGE>   9
STATE OF TEXAS            )
                          )
COUNTY OF DALLAS          )

         BEFORE ME, the undersigned authority, a Notary Public in and for said
state, on this day personally appeared Vicki A. Roberts and David A.
Greenblatt, known to me to be the persons and officers whose names are
subscribed to the foregoing instrument and acknowledged to me that the same was
the act of the said CENTEX CORPORATION, a Nevada corporation, and that they
executed the same as the act of said corporation for the purposes and
consideration therein expressed, and in the capacity therein stated.

         GIVEN UNDER MY HAND AND SEAL OF OFFICE, this 9th day of June, 1995.



                                       /S/ TONI M. GRIVAS                  
                                       ------------------------------------
                                       Notary Public in and for the     
                                       State of Texas                   
                                                                           
My commission expires:                 /S/ TONI M. GRIVAS                  
                                       ------------------------------------
                                       Printed Name of Notary Public       
12/31/96                                                                
- ---------------------------            




STATE OF TEXAS            )
                          )
COUNTY OF DALLAS          )

         BEFORE ME, the undersigned authority, a Notary Public in and for said
state, on this day personally appeared Wayne Mentz and JoAnne K. Gulliver,
known to me to be the persons and officers whose names are subscribed to the
foregoing instrument and acknowledged to me that the same was the act of the
said TEXAS COMMERCE BANK NATIONAL ASSOCIATION, a national banking association,
and that they executed the same as the act of said national banking association
for the purposes and consideration therein expressed, and in the capacity
therein stated.

         GIVEN UNDER MY HAND AND SEAL OF OFFICE, this 9th day of June, 1995.



                                       /S/ TONI M. GRIVAS    
                                       ----------------------------------
                                       Notary Public in and for the
                                       State of Texas
                                                 
My commission expires:                 /S/ TONI M. GRIVAS            
                                       ----------------------------------
                                       Printed Name of Notary Public     

12/31/96                               
- ----------------------------------






                                      -8-
<PAGE>   10
         No. 01                                             $100,000,000
   CUSIP No. 152312AD6


                                   EXHIBIT A

UNLESS THIS SUBORDINATED DEBENTURE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE
OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION ("DTC"), TO THE COMPANY
OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY
CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER
NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENCUSIPENo. 152312AD6ANY PAYMENT IS
MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED
REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR
OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED HOLDER
HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.



                               CENTEX CORPORATION

                7-3/8% SUBORDINATED DEBENTURES DUE JUNE 1, 2005


         CENTEX CORPORATION, a corporation duly organized and existing under
the laws of the State of Nevada (herein referred to as the "Company"), for
value received, hereby promises to pay to CEDE & CO. or registered assigns, the
principal sum of ONE HUNDRED MILLION AND NO/100 DOLLARS on June 1, 2005, in
such coin or currency of the United States of America as at the time of payment
is legal tender for the payment of public and private debts, and to pay
interest on said principal sum at the rate per annum specified in the title of
this Subordinated Debenture, with respect to interest accrued from June 9, 1995
to the date of the current interest payment, to the registered holder hereof as
of the close of business on the fifteenth day of the month preceding the month
in which an interest payment is due, in like coin or currency, all at any
office or agency of the Company to be maintained by the Company pursuant to
Section 5.02 of the Indenture, which at all times shall include an office or
agency in the Borough of Manhattan, The City of New York, such interest
payments to be made, except as otherwise provided in the Indenture hereinafter
referred to, on June 1 and December 1 in each year, commencing December 1,
1995, until payment of said principal sum has been made or duly provided for;
provided, however, that payment of interest may be made at the option of the
Company by check mailed on or before such payment date to the address of the
person entitled thereto as such address shall appear on the Subordinated Debt
Security Register.  Interest on the Subordinated Debentures shall be computed
based on a 360-day year comprised of twelve 30-day months.

         This Subordinated Debenture shall be deemed to be a contract made
under the laws of the State of Texas, and for all purposes shall be construed
in accordance with the laws of said State.

         Additional provisions of this Subordinated Debenture are contained on
the reverse hereof and such provisions shall for all purposes have the same
effect as though fully set forth at this place.

         This Subordinated Debenture shall not be valid or become obligatory
for any purpose until the certificate of authentication hereon shall have been
signed by the Trustee under the Indenture.
<PAGE>   11

         IN WITNESS WHEREOF, CENTEX CORPORATION has caused this instrument to
be signed in its corporate name by the signature of its President or a Vice
President, or a facsimile thereof, and by its Secretary or an Assistant
Secretary by his signature, or a facsimile thereof, and a facsimile of its
corporate seal to be affixed hereunto or imprinted hereon.


Dated:  June 9, 1995                              CENTEX CORPORATION


<TABLE>
<S>                                               <C>
                                                  By               
                                                    ---------------------------
         [SEAL]                                     Michael S. Albright,
                                                    Vice President - Finance and
                                                    Controller


ATTEST:

                                             
- ------------------------
David A. Greenblatt,
Assistant Secretary
</TABLE>



                    TRUSTEE'S CERTIFICATE OF AUTHENTICATION

         This is one of the Subordinated Debentures described in the
within-mentioned Indenture.

<TABLE>
<S>                                               <C>
                                                  TEXAS COMMERCE BANK NATIONAL
                                                  ASSOCIATION, as Trustee
                                                

                                                  By                       
                                                    ---------------------------
                                                    Authorized Signature
</TABLE>





                                      -10-
<PAGE>   12
                               CENTEX CORPORATION

                7-3/8% SUBORDINATED DEBENTURES DUE JUNE 1, 2005

         This Subordinated Debenture is one of a duly authorized issue of
Subordinated Debt Securities of the Company issued and to be issued in one or
more Series, and this Subordinated Debenture is one of the Series of
Subordinated Debt Securities designated as its 7-3/8% Subordinated Debentures
due June 1, 2005 (herein referred to as the "Subordinated Debentures"), limited
to the aggregate principal amount of One Hundred Million and No/100 Dollars
($100,000,000), all issued or to be issued under and pursuant to an Indenture
dated as of March 12, 1987 (herein referred to as the "Indenture"), duly
executed and delivered by the Company to Texas Commerce Bank National
Association, as trustee (referred to herein as the "Trustee"), to which
Indenture and all indentures supplemental thereto (including the Indenture
Supplement dated as of June 9, 1995 (the "Indenture Supplement"), which
authorizes the Subordinated Debentures) reference is hereby made for a
description of the rights, limitations of rights, obligations, duties and
immunities thereunder of the Trustee, the Company and the holders of the
Subordinated Debt Securities of each particular Series and the terms upon which
the Subordinated Debt Securities of each Series are, and are to be,
authenticated and delivered.  All terms used in this Subordinated Debenture
which are defined in the Indenture shall have the meanings assigned to them in
the Indenture.  In the event of any conflict between the terms of this
Subordinated Debenture and the Indenture Supplement, the latter shall control.
As provided in the Indenture, the Subordinated Debt Securities are issuable in
Series which may vary as in the Indenture provided or permitted.

         The indebtedness evidenced by the Subordinated Debentures is, to the
extent and in the manner provided in the Indenture, subordinated and subject in
right of payment to the prior payment in full of all Senior Indebtedness of the
Company.  As provided in the Indenture, each holder of this Subordinated
Debenture, by his acceptance hereof, agrees to and shall be bound by all the
provisions of the Indenture relating to such subordination and authorizes the
Trustee to take such action in his behalf as may be necessary or appropriate to
effectuate the subordination as provided in the Indenture and appoints the
Trustee his attorney-in-fact for any and all such purposes.

         In case an Event of Default shall have occurred and be continuing with
respect to the Subordinated Debentures, the principal hereof may be declared,
and upon such declaration shall become, due and payable, in the manner, with
the effect and subject to the conditions provided in the Indenture.  The
Indenture provides that in certain events such declaration and its consequences
may be waived by the holders of a majority in aggregate principal amount of the
Subordinated Debentures then outstanding.  An Event of Default with respect to
the Subordinated Debt Securities of any other Series issued under the
Indenture, including the failure to make any payment of principal or interest
with respect thereto when and as due, will not be an Event of Default with
respect to Subordinated Debentures.

         The Indenture contains provisions permitting the Company and the
Trustee, with the consent of the holders of not less than a majority in
aggregate principal amount of the Subordinated Debentures at the time
outstanding, evidenced as in the Indenture provided, to execute supplemental
indentures adding any provisions to or changing in any manner or eliminating
any of the provisions of the Indenture or of any supplemental indenture or
modifying in any manner the rights of the holders of the Subordinated
Debentures; provided, however, that no such supplemental indenture shall (i)
extend the fixed maturity of any Subordinated Debentures, or reduce the
principal amount thereof, or reduce the rate or extend the time of payment of
interest thereon, without the consent of the holder of each Subordinated
Debenture so affected, or (ii) reduce the aforesaid percentage of Subordinated
Debentures, the consent of the holders of which is required for any such
supplemental indenture, without the consent of the holders of all Subordinated
Debentures then outstanding.  It is also provided in the Indenture that the
holders of a majority in aggregate principal amount of the Subordinated
Debentures at the time outstanding may on





                                      -11-
<PAGE>   13
behalf of the holders of all the Subordinated Debentures waive any past default
under the Indenture and its consequences, except a default in the payment of
the principal of or interest on any of the Subordinated Debentures.  Any such
consent or waiver by the holder of this Subordinated Debenture (unless revoked
as provided in the Indenture) shall be conclusive and binding upon such holder
and upon all future holders and owners of this Subordinated Debenture and of
any Subordinated Debenture issued in exchange or substitution herefor, whether
or not any notation of such consent or waiver is made upon this Subordinated
Debenture.

         Subject to the rights of holders of Senior Indebtedness of the Company
set forth in the Indenture, no reference herein to the Indenture and no
provision of this Subordinated Debenture or of the Indenture shall alter or
impair the obligation of the Company, which is absolute and unconditional, to
pay the principal of and interest on this Subordinated Debenture at the place,
at the respective times, at the rate and in the currency herein prescribed.

         The Subordinated Debentures are issuable in registered form in
denominations of $100,000 and any integral multiple of $5,000 above such
amount.  Thereafter, upon reregistration, exchange or transfer, the Debentures
are issuable in denominations of $1,000 and integral multiples thereof.

         The Subordinated Debentures are not subject to redemption prior to
maturity.  No Sinking Fund has been created with respect to the Subordinated
Debentures and they are not subject to any Sinking Fund payments.

         Upon due presentment for registration of transfer of this Subordinated
Debenture at any designated office or agency of the Company to be maintained by
the Company pursuant to Section 5.02 of the Indenture, which at all times shall
include an office or agency in the Borough of Manhattan, The City of New York,
a new Subordinated Debenture or Subordinated Debentures of authorized
denominations for an equal aggregate principal amount will be issued to the
transferee in exchange herefor, subject to the limitations provided in the
Indenture, without charge except for any tax or other governmental charge
imposed in connection therewith, and the Subordinated Debentures may in like
manner be exchanged for one or more new Subordinated Debentures of other
authorized denominations but of the same aggregate principal amount.

         The Company, the Trustee, any paying agent and any Subordinate Debt
Security Registrar (as defined in the Indenture) for the Subordinated
Debentures may deem and treat the registered holder hereof as the absolute
owner of this Subordinated Debenture (whether or not this Subordinated
Debenture shall be overdue and notwithstanding any notation of ownership or
other writing hereon made by anyone other than the Company or any such
Subordinated Debt Security Registrar), for the purpose of receiving payment
hereof or on account hereof and for all other purposes, and neither the Company
nor the Trustee nor any paying agent nor any such Subordinated Debt Security
Registrar shall be affected by any notice to the contrary.

         No recourse shall be had for the payment of the principal of or
interest on this Subordinated Debenture, or for any claim based hereon or
otherwise in respect hereof, or based on or in respect of the Indenture or any
indenture supplemental thereto, against any incorporator, stockholder, officer
or director, as such, past, present or future, of the Company or of any
successor corporation, whether by virtue of any constitution, statute or rule
of law, or by the enforcement of any assessment or penalty or otherwise, all
such liability being, by the acceptance hereof and as part of the consideration
for the issue hereof, expressly waived and released.

                         _____________________________





                                      -12-


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission